At Telix, we are united by a common purpose – to help people living with cancer and rare diseases live longer, better quality lives.
Since launching our first product in April this year, we have been able to help over 1,000 men a week living with prostate cancer, supporting thousands of other patients around the world through clinical trials and compassionate use programs. This purpose will continue to drive us in 2023 and beyond.
This Christmas, our thoughts are with those whose lives continue to be touched by cancer. In honour of them we will be making donations to Zero – The End of Prostate Cancer, and Kidney Cancer Association.
We also thank you - our clinical collaborators, partners, shareholders and friends who have supported us in the journey so far. We wish you and your families a peaceful and happy holiday season.
In case some didn`t get the email this morning
Ann: 1H 2022 - Results Presentation, page-82
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.93 |
Change
-0.010(0.05%) |
Mkt cap ! $6.620B | |||
| Open | High | Low | Value | Volume |
| $19.77 | $20.47 | $19.66 | $30.07M | 1.504M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 862 | $19.92 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.95 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |